Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
Clinical trial NCT01363440 · COMPLETED
Trial details
- NCT number
- NCT01363440
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-01-01
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.